Abstract
A clinical decision report using:
Beigel JH, Tomashek KM, Dodd LE, et al. Remdesivir for the Treatment of Covid-19 — Final Report. N Engl J Med. 2020;383:1813-1826. https://doi.org/10.1056/NEJMoa2007764
for a patient with severe COVID-19.
DOI
10.22237/crp/1625097660
Creative Commons License
This work is licensed under a Attribution 4.0 International (CC-BY 4.0) License
Recommended Citation
BURDICK G. Remdesivir has questionable efficacy in patients with severe COVID-19 receiving high-flow oxygen. Clin. Res. Prac. Oct 13 2021;7(2):eP2522. https://doi.org/10.22237/crp/1625097660
Included in
Bioethics and Medical Ethics Commons, Internal Medicine Commons, Medical Education Commons, Pulmonology Commons, Respiratory Tract Diseases Commons, Virus Diseases Commons
